Merdad Parsey insider trades

Open-market stock purchases and sales by Merdad Parsey, Director at ArriVent BioPharma, Inc, from SEC Form 4 filings since Nov 10, 2019.

Recent trades

DateStockTradeValue
Jun 18, 2026AVBP ArriVent BioPharma, IncBought (not open market)—
Jun 16, 2026ARDX Ardelyx, IncBought (not open market)—
Jun 16, 2026ARDX Ardelyx, IncBought (not open market)—

Companies traded

  • AVBP ArriVent BioPharma, Inc: other filings, last Jun 18, 2026
  • ARDX Ardelyx, Inc: other filings, last Jun 16, 2026
  • GILD Gilead Sciences, Inc: 19 sales, last Dec 10, 2024
  • SGMT Sagimet Biosciences Inc: other filings, last Jun 5, 2024

Get free alerts when Merdad Parsey files a new trade →